Pfizer
Canada health regulator approves Pfizer's COVID-19 vaccine
Canada's health regulator on Wednesday approved Pfizer’s COVID-19 vaccine, days ahead of possible approval in the United States.
UK probing if allergic reactions linked to Pfizer vaccine
British regulators warned Wednesday that people who have a history of serious allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on the first day of the country’s mass vaccination program.
US regulators post positive review of Pfizer vaccine data
Documents released by U.S. regulators Tuesday confirmed that Pfizer and BioNTech’s COVID-19 vaccine was strongly protective against COVID-19 -- offering the world’s first detailed look at the evidence behind the shots.
UK gears up for huge vaccination plan watched by the world
The coronavirus vaccine developed by American drugmaker Pfizer and Germany’s BioNTech was being sent to hospitals across the U.K. in super-cold containers on Sunday, two days ahead of the kickoff of Britain’s biggest-ever immunization program, one being closely watched around the world.
Official optimistic virus vaccine will be OK’d
A top medical adviser to President Donald Trump’s administration saId Sunday he’s confident that the Food and Drug Administration will approve the coronavirus vaccine from pharmaceutical company Pfizer this week.
UK authorizes Pfizer vaccine for emergency use
Pfizer and BioNTech say they've won permission Wednesday for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic.
European regulator to decide Dec. 29 on 1st virus vaccine
The European Medicines Agency will convene a meeting on Dec. 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved, the regulator said Tuesday.
Moderna asking US, European regulators to OK its virus shots
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.
Pfizer, BioNTech seek emergency use of COVID-19 shots in US
Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.
Pfizer asks regulators for emergency vaccine use
Pfizer will ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month.